Xponance, Inc.

SEC CIK: 0001637541
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

VNDA holding history

Vanda Pharmaceuticals Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VNDA overview All 13F holders of VNDA Full Q2 2026 holdings

Shares (Q4 2023): 0; Sold out in Q4 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2023

Holdings of VNDA by Xponance, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2023	0	$0	0.0%	−16,427−100.0%	Sold out	Holders
Q3 2023	16,427	$71.0K	<0.1%	−1,392−7.8%	Reduced	Holders
Q2 2023	17,819	$117.4K	<0.1%	+17,819	New	Holders